Certinib is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive
| Country of origin | Grade |
| China | Pharma Grade |
Menu
Certinib is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive
| Country of origin | Grade |
| China | Pharma Grade |
Registered Address:
78 Fakirapool, Motijheel,
Dhaka 1000, Bangladesh
Corporate Address:
674/23 Shahjalal Housing (SPBn),
Basila Road, Dhaka 1205
Email: ceo@redox-bd.com